Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Novoprotein(688137) the Revenue is 37.25 M (+11.37%);the EBIT is -12.23 M (+20.87%);the EPS is -0.15 (+11.76%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.04B11.37%
----
----
EBIT
-0.01B20.87%
----
----
EPS
-0.1511.76%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf